Skip to main content
Clinical Trials/NCT05065060
NCT05065060
Recruiting
Not Applicable

Parkinson's Progression Markers Initiative Online Study (PPMI Online)

Michael J. Fox Foundation for Parkinson's Research1 site in 1 country500,000 target enrollmentJuly 28, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Michael J. Fox Foundation for Parkinson's Research
Enrollment
500000
Locations
1
Primary Endpoint
Unified Parkinson's Disease Rating Scale Ib & II
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Parkinson Progression Marker Initiative Online (PPMI Online) is an observational study collecting participant reported information from people with and without Parkinson's disease (PD), for the goal of better understanding risk and predictive factors for PD.

PPMI Online is part of the broader Parkinson Progression Marker Initiative aimed at identifying markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.

Detailed Description

PPMI is a broad program that is expanding the goals of the original PPMI study, and will include this PPMI Online protocol, as well the PPMI Clinical \[NCT04477785\], PPMI Remote, PPMI Digital protocols (with external regulatory oversight). All participants in PPMI may be asked to participate in one or all of these protocols and their enrollment in these studies may occur in varying order. PPMI participants may also be asked to participate in additional PPMI companion studies (as they are developed), which may only involve a subset of PPMI participants based on their cohort designation

Registry
clinicaltrials.gov
Start Date
July 28, 2021
End Date
December 2041
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Michael J. Fox Foundation for Parkinson's Research
Responsible Party
Principal Investigator
Principal Investigator

Caroline M Tanner

Protocol Co- Principal Investigator

University of California, San Francisco

Eligibility Criteria

Inclusion Criteria

  • Parkinson Disease (PD) Participants:
  • Male or female age 18 years or older.
  • Has received a diagnosis of Parkinson's disease
  • Participants without PD:
  • Male or female age 18 years or older.
  • Has not received a diagnosis of Parkinson's disease

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Unified Parkinson's Disease Rating Scale Ib & II

Time Frame: Baseline to 240 months

Evaluates self-reported motor and nonmotor Parkinson's disease symptoms

Study Sites (1)

Loading locations...

Similar Trials